Edge Wealth Management LLC Novo Cure LTD Transaction History

Edge Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$60.15 - $84.52 $4,812 - $6,761	-80 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$75.08 - $121.99 $3,003 - $4,879	40 Added 100.0%	80 $6,000
Q4 2021 Jan 14, 2022	SELL	$75.08 - $121.99 $3,003 - $4,879	-40 Reduced 50.0%	40 $6,000
Q1 2020 Apr 20, 2020	SELL	$57.05 - $95.75 $12.9 Million - $21.7 Million	-226,524 Reduced 99.96%	80 $5,000
Q4 2019 Jan 29, 2020	BUY	$68.3 - $93.8 $15.5 Million - $21.2 Million	226,524 Added 283155.0%	226,604 $1.78 Million
Q4 2017 Jan 18, 2018	BUY	$16.3 - $21.9 $1,304 - $1,752	80	80 $1,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.